
U.S. stocks were higher, with the Dow Jones index gaining more than 400 points on Monday.
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO) rose sharply during Monday's session after the company announced that the FDA approved Attruby to treat adults with ATTR-CM.